Open AccessPaclitaxel based vs oxaliplatin based regimens for advanced gastric cancer
Author(s) -
Xiaodong Li,
Hua Shen,
Jingting Jiang,
Hanze Zhang,
Xiao Zheng,
Yongqian Shu,
Changping Wu
Publication year - 2011
Publication title -
world journal of gastroenterology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v17.i8.1082
Subject(s) - oxaliplatin , folfox , fluorouracil , medicine , gastroenterology , neutropenia , nausea , anemia , survival rate , vomiting , paclitaxel , regimen , cisplatin , chemotherapy , cancer , surgery , colorectal cancer
To compare the efficacy and safety of paclitaxel combined with fluorouracil plus cisplatin (PCF), and oxaliplatin combined with fluorouracil plus leucovorin (FOLFOX-4) regimens for advanced gastric cancer (AGC).